# Decoding lung-kidney interactions in sepsis: an integrated view of molecular mechanisms, pathophysiology, and therapeutic interventions

**Authors:** Chenye Ma, Hongyi Li, Zirong Chen, Heng Song, Yuze Wang, Zhihui Liu, Xuefan Bu, Xianfei Ding, Hanfang Si, Jinghua Yang, Tongwen Sun

PMC · DOI: 10.3389/fimmu.2026.1736900 · Frontiers in Immunology · 2026-02-18

## TL;DR

This review explores how lung and kidney dysfunction interact in sepsis, highlighting their mutual impact and potential for new treatment strategies.

## Contribution

The paper provides an integrated analysis of lung-kidney crosstalk in sepsis, summarizing molecular, pathophysiological, and therapeutic insights.

## Key findings

- Lung and kidney dysfunction in sepsis are interdependent, increasing mortality risk.
- Cytokines and bio-active substances from the kidney can cause lung injury in sepsis.
- Therapeutic interventions like mechanical ventilation and renal replacement therapy can worsen organ dysfunction.

## Abstract

Sepsis, a great health concern globally, is characterized by multi-organ dysfunction and high mortality rate. As highly vascularized organs, the kidney and lung are the most susceptible in sepsis. Moreover, the loss of normal function in either of them may increase the risk of injury to the other, and the combined dysfunction of the respiratory system and the renal system may significantly increase the mortality rate of sepsis patients. As a part of systematic response, soluble cytokines and inflammatory mediators released from lung and kidney would exacerbate overall immune disorder, while bio-active substances like lipocalin-2, α-klotho, osteopontin released by kidney, metabolites and extracellular vesicles in sepsis can spread by circulation and induce injuries of distant tissues in lung. Furthermore, water-sodium and acid-base imbalance, as well as oxidative stress induced by kidney injury exacerbate respiratory distress in sepsis patients; while hypoxemia, hypercapnia, hemodynamic changes and endothelial injury induced by lung injury in sepsis can reduce the glomerular filtration rate. In addition, hemodynamic, neurohormonal, and immune-mediated processes induced by invasive mechanical ventilation exacerbate kidney dysfunction; pulmonary hypertension and the subsequent series of changes induced by renal replacement therapy also reduce the oxygenation in sepsis patients. As an important example of organ function network imbalance induced by sepsis, lung-kidney crosstalk involves multi-level interactions and may serve as the basis for sequential organ failure in sepsis. In this review, we summarized the scattered research advancement related to the lung-kidney interaction in sepsis, covering molecular mechanisms, pathophysiological mechanisms, as well as the impact of support therapies. Despite the lack of therapeutic targets verified by clinical research, preclinical studies have nonetheless uncovered some promising results that may offer new intervention strategies. A deep understanding of organ-organ axes represented by lung-kidney crosstalk, may provide insights into the early mechanisms of sepsis-related multiple-organ dysfunction and potential therapeutic strategies. Future research needs to distinguish the relationship between therapeutic interventions and lung-kidney interactions, integrating a broader molecular landscape and more precise animal models, or organ chips, to deeply disclose the dysregulation of organ interaction in sepsis, in order to develop more precise intervention strategies.

Infographic illustrating lung-kidney interaction divided into four sections: molecular mechanisms (cytokine, inflammatory mediators, metabolites, EVs), pathological mechanisms (acid-base imbalance, inflammation, oxidative stress, hemodynamic changes), clinical interventions (RRT to lung, IMV to kidney), and treatment (clinical interventions and trials, preclinical studies), with corresponding icons for each category.

## Full-text entities

- **Genes:** Angpt2 (angiopoietin 2) [NCBI Gene 11601] {aka Agpt2, Ang-2, Ang2}, POMC (proopiomelanocortin) [NCBI Gene 5443] {aka ACTH, CLIP, LPH, MSH, NPP, OBAIRH}, IL11 (interleukin 11) [NCBI Gene 3589] {aka AGIF, IL-11}, ANPEP (alanyl aminopeptidase, membrane) [NCBI Gene 290] {aka AP-M, AP-N, APN, CD13, GP150, LAP1}, AZU1 (azurocidin 1) [NCBI Gene 566] {aka AZAMP, AZU, CAP37, HBP, HUMAZUR, NAZC}, TRPV4 (transient receptor potential cation channel subfamily V member 4) [NCBI Gene 59341] {aka BCYM3, CMT2C, HMSN2C, OTRPC4, SMAL, SPSMA}, FPR2 (formyl peptide receptor 2) [NCBI Gene 2358] {aka ALX, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH1}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, PADI4 (peptidyl arginine deiminase 4) [NCBI Gene 23569] {aka PAD, PAD4, PADI5, PDI4, PDI5}, KPNB1 (karyopherin subunit beta 1) [NCBI Gene 3837] {aka IMB1, IPO1, IPOB, Impnb, NTF97}, NOS3 (nitric oxide synthase 3) [NCBI Gene 4846] {aka EC-NOS, ECNOS, MYMY8, NOSIII, cNOS, eNOS}, RHOA (ras homolog family member A) [NCBI Gene 387] {aka ARH12, ARHA, EDFAOB, RHO12, RHOH12}, VEGFA (vascular endothelial growth factor A) [NCBI Gene 7422] {aka L-VEGF, MVCD1, VEGF, VPF}, MIR146A (microRNA 146a) [NCBI Gene 406938] {aka MIRN146, MIRN146A, miR-146a, miRNA146A}, MAPK14 (mitogen-activated protein kinase 14) [NCBI Gene 1432] {aka CSBP, CSBP1, CSBP2, CSPB1, EXIP, Mxi2}, TNFRSF1A (TNF receptor superfamily member 1A) [NCBI Gene 7132] {aka CD120a, FPF, TBP1, TNF-R, TNF-R-I, TNF-R55}, REN (renin) [NCBI Gene 5972] {aka ADTKD4, HNFJ2, RTD}, SLC22A17 (solute carrier family 22 member 17) [NCBI Gene 51310] {aka 24p3R, BOCT, BOIT, NGALR, NGALR2, NGALR3}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CASP3 (caspase 3) [NCBI Gene 836] {aka CPP32, CPP32B, SCA-1}, HMOX1 (heme oxygenase 1) [NCBI Gene 3162] {aka HMOX1D, HO-1, HSP32, bK286B10}, NPPA (natriuretic peptide A) [NCBI Gene 4878] {aka ANF, ANP, ATFB6, ATRST2, CDD, CDD-ANF}, HSPB2 (heat shock protein family B (small) member 2) [NCBI Gene 3316] {aka HSP27, Hs.78846, LOH11CR1K, MKBP}, MIR19B1 (microRNA 19b-1) [NCBI Gene 406980] {aka C13orf25, MIR19B, MIRH1, MIRHG1, MIRN19B1, miR-19b-1}, SAR1B (secretion associated Ras related GTPase 1B) [NCBI Gene 51128] {aka ANDD, CMRD, GTBPB, SARA2}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, LGALS3 (galectin 3) [NCBI Gene 3958] {aka CBP35, GAL3, GALBP, GALIG, L31, LGALS2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, TNFRSF1B (TNF receptor superfamily member 1B) [NCBI Gene 7133] {aka CD120b, TBPII, TNF-R-II, TNF-R75, TNFBR, TNFR1B}, IL7 (interleukin 7) [NCBI Gene 3574] {aka IL-7, IMD130}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, Vcam1 (vascular cell adhesion molecule 1) [NCBI Gene 22329] {aka CD106, Vcam-1}, ANXA1 (annexin A1) [NCBI Gene 301] {aka ANX1, LPC1}, SFTPA1 (surfactant protein A1) [NCBI Gene 653509] {aka COLEC4, ILD1, PSP-A, PSPA, SFTP1, SFTPA1B}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}, GP6 (glycoprotein VI platelet) [NCBI Gene 51206] {aka BDPLT11, GPIV, GPVI}, ITGAM (integrin subunit alpha M) [NCBI Gene 3684] {aka CD11B, CR3A, HNA-4, MAC-1, MAC1A, MO1A}, CD47 (CD47 molecule) [NCBI Gene 961] {aka IAP, MER6, OA3}, FABP1 (fatty acid binding protein 1) [NCBI Gene 2168] {aka FABPL, L-FABP}, ELANE (elastase, neutrophil expressed) [NCBI Gene 1991] {aka ELA2, GE, HLE, HNE, NE, PMN-E}, TREM1 (triggering receptor expressed on myeloid cells 1) [NCBI Gene 54210] {aka CD354, TREM-1}, LCN2 (lipocalin 2) [NCBI Gene 3934] {aka 24p3, MSFI, NGAL, p25}, MIR23A (microRNA 23a) [NCBI Gene 407010] {aka MIRN23A, hsa-mir-23a, miRNA23A, mir-23a}, MPO (myeloperoxidase) [NCBI Gene 4353], CCL2 (C-C motif chemokine ligand 2) [NCBI Gene 6347] {aka GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, AQP5 (aquaporin 5) [NCBI Gene 362] {aka AQP-5, PPKB}, SPP1 (secreted phosphoprotein 1) [NCBI Gene 6696] {aka BNSP, BSPI, ETA-1, OPN}, AHR (aryl hydrocarbon receptor) [NCBI Gene 196] {aka FVH3, RP85, bHLHe76}, CALML3 (calmodulin like 3) [NCBI Gene 810] {aka CLP}, Vegfa (vascular endothelial growth factor A) [NCBI Gene 22339] {aka L-VEGF, Vegf, Vpf}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}, FGFR1 (fibroblast growth factor receptor 1) [NCBI Gene 2260] {aka BFGFR, CD331, CEK, ECCL, FGFBR, FGFR-1}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL1A (interleukin 1 alpha) [NCBI Gene 3552] {aka IL-1 alpha, IL-1A, IL1, IL1-ALPHA, IL1F1}, SLC22A8 (solute carrier family 22 member 8) [NCBI Gene 9376] {aka OAT3}, Nfkb1 (nuclear factor of kappa light polypeptide gene enhancer in B cells 1, p105) [NCBI Gene 18033] {aka NF-KB1, NF-kappaB, NF-kappaB1, p105, p50, p50/p105}
- **Diseases:** necrotic (MESH:D009336), fistula (MESH:D005402), acute physiology (MESH:D000208), septic (MESH:D001170), ARDS (MESH:D012128), septic shock (MESH:D012772), hyperuricemia (MESH:D033461), pulmonary dysfunction (MESH:D011660), ischemia (MESH:D007511), hypotension (MESH:D007022), immune dysregulation (OMIM:614878), renal and pulmonary injury (MESH:D011665), Hypoxemia (MESH:D000860), Sepsis (MESH:D018805), pulmonary hypertension (MESH:D006976), injuries of distant tissues (MESH:D017695), damage (MESH:D020263), pulmonary apoptosis (MESH:D065703), hypoxic (MESH:D002534), kidney damage (MESH:D007674), DNA (MESH:D004266), Right heart failure (MESH:D006333), MODS (MESH:D009102), multi-organ damage (MESH:D000092124), bacterial infections (MESH:D001424), cardiac dysfunction (MESH:D006331), lung inflammation (MESH:D011014), Hypercapnia (MESH:D006935), venous congestion (MESH:D006940), system (MESH:D015619), AKI (MESH:D058186), pulmonary inflammatory (MESH:D016726), paralysis (MESH:D010243), lymphopenia (MESH:D008231), thrombocytopenia (MESH:D013921), immune disorder (MESH:D007154), end-stage renal disease (MESH:D007676), COVID-19 (MESH:D000086382), Klebsiella pneumoniae (MESH:D007710), lung (MESH:D008171), systemic inflammatory response syndrome (MESH:D018746), infection (MESH:D007239), congestion (MESH:D002311), failure (MESH:D051437), right ventricular dysfunction (MESH:D018497), uremic toxins (MESH:D006463), hemorrhagic shock (MESH:D012771), secondary hyperparathyroidism (MESH:D006962), kidney and lung injury (MESH:D055370), chronic kidney disease (MESH:D051436), lung edema (MESH:D004487), intraabdominal hypertension (MESH:D059325), Cardiogenic pulmonary edema (MESH:D011654), ALI (MESH:D055371), IR (MESH:C537629), critically ill (MESH:D016638), cardiogenic (MESH:D013575), ventricular overload (MESH:D019190), TECs (MESH:D009375), Inflammation (MESH:D007249)
- **Chemicals:** N-acetylcysteine (MESH:D000111), Sarilumab (MESH:C000592401), adenine (MESH:D000225), vitamin C (MESH:D001205), calcium (MESH:D002118), chloride (MESH:D002712), hemin (MESH:D006427), ROS (MESH:D017382), Clazakizumab (MESH:C000604955), artesunate (MESH:D000077332), Sivelestat (MESH:C069195), ADMA (MESH:C018524), NO (MESH:D009569), creatinine (MESH:D003404), Sodium hydrosulfide (MESH:C025451), water (MESH:D014867), IS (MESH:D007455), urea nitrogen (MESH:C530477), iron (MESH:D007501), LPS (MESH:D008070), MDA (MESH:D015104), p-cresyl sulfate (MESH:C408690), prostaglandin (MESH:D011453), Uric acid (MESH:D014527), hydrocortisone (MESH:D006854), thiamine (MESH:D013831), pirfenidone (MESH:C093844), lactate (MESH:D019344), Coenzyme Q10 (MESH:C024989), carbohydrate (MESH:D002241), malondialdehyde (MESH:D008315), aldosterone (MESH:D000450), phenylalanine (MESH:D010649), Curcumin (MESH:D003474), ADQI (-), Tocilizumab (MESH:C502936), Nangibotide (MESH:C420324), sodium (MESH:D012964), acetaminophen (MESH:D000082), indoxyl sulfate (MESH:D007200), Sirukumab (MESH:C568922), adrecizumab (MESH:C000706631)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606], Mycobacterium intracellulare subsp. intracellulare (subspecies) [taxon 35617]
- **Cell lines:** TEC — Scophthalmus maximus (Turbot), Spontaneously immortalized cell line (CVCL_J026)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957108/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957108/full.md

## References

193 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957108/full.md

---
Source: https://tomesphere.com/paper/PMC12957108